338 related articles for article (PubMed ID: 32771878)
1. CARD9 mediates T cell inflammatory response in Coxsackievirus B3-induced acute myocarditis.
Sun C; Zhang X; Yu Y; Li Z; Xie Y
Cardiovasc Pathol; 2020; 49():107261. PubMed ID: 32771878
[TBL] [Abstract][Full Text] [Related]
2. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
Tschöpe C; Müller I; Xia Y; Savvatis K; Pappritz K; Pinkert S; Lassner D; Heimesaat MM; Spillmann F; Miteva K; Bereswill S; Schultheiss HP; Fechner H; Pieske B; Kühl U; Van Linthout S
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912259
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
[TBL] [Abstract][Full Text] [Related]
4. Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis.
Wang Y; Gao B; Xiong S
Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1438-47. PubMed ID: 25260607
[TBL] [Abstract][Full Text] [Related]
5. Blockade of interleukin-17A protects against coxsackievirus B3-induced myocarditis by increasing COX-2/PGE2 production in the heart.
Xie Y; Chen R; Zhang X; Yu Y; Yang Y; Zou Y; Ge J; Chen H; Garzino-Demo A
FEMS Immunol Med Microbiol; 2012 Apr; 64(3):343-51. PubMed ID: 22141571
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in coxsackievirus B3-induced myocarditis: IL-12Rbeta1 signaling and IFN-gamma increase inflammation in males independent from STAT4.
Frisancho-Kiss S; Nyland JF; Davis SE; Frisancho JA; Barrett MA; Rose NR; Fairweather D
Brain Res; 2006 Dec; 1126(1):139-47. PubMed ID: 16949558
[TBL] [Abstract][Full Text] [Related]
8. IL-21R expression on CD8+ T cells promotes CD8+ T cell activation in coxsackievirus B3 induced myocarditis.
Liu W; Dienz O; Roberts B; Moussawi M; Rincon M; Huber SA
Exp Mol Pathol; 2012 Jun; 92(3):327-33. PubMed ID: 22465422
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of IL-2 inducible T-cell kinase alleviates T-cell activation and murine myocardial inflammation associated with CVB3 infection.
He F; Yao H; Xiao Z; Han J; Zou J; Liu Z
Mol Immunol; 2014 May; 59(1):30-8. PubMed ID: 24462896
[TBL] [Abstract][Full Text] [Related]
10. Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy.
Westermann D; Savvatis K; Lindner D; Zietsch C; Becher PM; Hammer E; Heimesaat MM; Bereswill S; Völker U; Escher F; Riad A; Plendl J; Klingel K; Poller W; Schultheiss HP; Tschöpe C
Circulation; 2011 Nov; 124(19):2082-93. PubMed ID: 21986287
[TBL] [Abstract][Full Text] [Related]
11. Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis.
Weithauser A; Bobbert P; Antoniak S; Böhm A; Rauch BH; Klingel K; Savvatis K; Kroemer HK; Tschope C; Stroux A; Zeichhardt H; Poller W; Mackman N; Schultheiss HP; Rauch U
J Am Coll Cardiol; 2013 Nov; 62(19):1737-45. PubMed ID: 23871888
[TBL] [Abstract][Full Text] [Related]
12. α-Galactosylceramide protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis.
Wu CY; Feng Y; Qian GC; Wu JH; Luo J; Wang Y; Chen GJ; Guo XK; Wang ZJ
Clin Exp Immunol; 2010 Oct; 162(1):178-87. PubMed ID: 20726989
[TBL] [Abstract][Full Text] [Related]
13. CX3CR1 knockout aggravates Coxsackievirus B3-induced myocarditis.
Müller I; Pappritz K; Savvatis K; Puhl K; Dong F; El-Shafeey M; Hamdani N; Hamann I; Noutsias M; Infante-Duarte C; Linke WA; Van Linthout S; Tschöpe C
PLoS One; 2017; 12(8):e0182643. PubMed ID: 28800592
[TBL] [Abstract][Full Text] [Related]
14. [Effect of IL-17A on levels of antiheart autoantibodies in mice with viral myocarditis].
Lai W; Wu W; Pan X; Kong Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):601-3, 607. PubMed ID: 24909282
[TBL] [Abstract][Full Text] [Related]
15. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
16. c-FLIP-Short reduces type I interferon production and increases viremia with coxsackievirus B3.
Buskiewicz IA; Koenig A; Roberts B; Russell J; Shi C; Lee SH; Jung JU; Huber SA; Budd RC
PLoS One; 2014; 9(5):e96156. PubMed ID: 24816846
[TBL] [Abstract][Full Text] [Related]
17. The outcome of coxsackievirus B3-(CVB3-) induced myocarditis is influenced by the cellular immune status.
Leipner C; Grün K; Borchers M; Stelzner A
Herz; 2000 May; 25(3):245-8. PubMed ID: 10904846
[TBL] [Abstract][Full Text] [Related]
18. The adapter protein c-Cbl-associated protein (CAP) protects from acute CVB3-mediated myocarditis through stabilization of type I interferon production and reduced cytotoxicity.
Valaperti A; Nishii M; Liu Y; Yang H; Naito K; Liu PP; Eriksson U
Basic Res Cardiol; 2014 May; 109(3):411. PubMed ID: 24763933
[TBL] [Abstract][Full Text] [Related]
19. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.
Glück B; Schmidtke M; Merkle I; Stelzner A; Gemsa D
J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341
[TBL] [Abstract][Full Text] [Related]
20. Coxsackievirus B3-induced myocarditis in MHC class II-deficient mice.
Leipner C; Borchers M; Merkle I; Stelzner A
J Hum Virol; 1999; 2(2):102-14. PubMed ID: 10225212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
